Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1

Fibroblast growth factor 2 (FGF-2) is overexpressed in a subset of invasive bladder carcinomas and its overexpression correlates with poor prognosis. Analyses of publicly available databases addressing the molecular mechanisms that may be responsible for the poor prognosis of these tumors, revealed...

Descripción completa

Detalles Bibliográficos
Autores principales: McNiel, Elizabeth A, Tsichlis, Philip N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431749/
https://www.ncbi.nlm.nih.gov/pubmed/28515962
http://dx.doi.org/10.1038/sigtrans.2016.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431749/
https://www.ncbi.nlm.nih.gov/pubmed/28515962
http://dx.doi.org/10.1038/sigtrans.2016.45

Ejemplares similares